Skip to content

Home
Our research
Market
Plans
Partnering
About us

Menu

Home
Our research
Market
Plans
Partnering
About us

BIO Convention

Follicum deltar på konferensen BIO Convention i Philadelphia 3-6 juni 2019

Mer information

Contact us

Tore Duvold

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising dermacosmetic product line based on FOL005 to stimulate hair growth. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved